Human CD3 epsilon Protein, Mouse IgG2a Fc Tag (MALS verified)
分子別名(Synonym)
FLJ18683,T3E,TCRE,CD3E,CD3-epsilon
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human CD3 epsilon, Mouse IgG2a Fc Tag (CDN-H5253) is expressed from human 293 cells (HEK293). It contains AA Asp 23 - Asp 126 (Accession # NP_000724.1).
Predicted N-terminus: Asp 23
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a mouse IgG2a Fc tag at the C-terminus.
The protein has a calculated MW of 38.6 kDa. The protein migrates as 43-50 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in 50 mM Tris, 100 mM Glycine, 25 mM Arginine, 150 mM NaCl, pH7.5 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
CD3e分子,ε也稱為CD3e,是一種T細(xì)胞表面單程I型膜糖蛋白。CD3E含有1個(gè)Ig樣(免疫球蛋白樣)結(jié)構(gòu)域和1個(gè)ITAM結(jié)構(gòu)域。CD3E與CD3γ、CD3δ和CD3ζ以及T細(xì)胞受體α/β和γ/δ異二聚體一起形成T細(xì)胞受體-CD3復(fù)合物。該復(fù)合物在將抗原識(shí)別與幾種細(xì)胞內(nèi)信號(hào)轉(zhuǎn)導(dǎo)通路偶聯(lián)方面起著重要作用。編碼ε、γ和δ多肽的基因位于11號(hào)染色體上的同一簇中。ε多肽在T細(xì)胞發(fā)育中起著至關(guān)重要的作用。CD3E在T細(xì)胞發(fā)育中起著至關(guān)重要的作用,CD3E基因的缺陷會(huì)導(dǎo)致嚴(yán)重的免疫缺陷。CD3E基因也與女性患I型糖尿病的易感性有關(guān)。CD3E已被證明與TOP2B、CD3EAP和NCK2相互作用。
關(guān)鍵字: CD3 epsilon;CD3E蛋白;CD3E重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。